{"nct_id":"NCT07142642","title":"A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2025-08-26","start_date_type":"ACTUAL","primary_completion_date":"2025-11-22","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11-22","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["AMGN"]}